Direxion Daily S&P Biotech Bear 3X ETF
LABD
18 hedge funds and large institutions have $9.5M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
474% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $2.01M
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
20% more funds holding
Funds holding: 15 → 18 (+3)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
19.15% less ownership
Funds ownership: 38.81% → 19.65% (-19%)
55% less capital invested
Capital invested by funds: $21.2M → $9.5M (-$11.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.61M |
| 3 |
JF
Jump Financial
Chicago,
Illinois
|
+$799K |
| 4 |
Goldman Sachs
New York
|
+$463K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$399K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$7.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.85M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.3M |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$1.04M |
| 5 |
HF
HRT Financial
New York
|
-$444K |
LABD Hedge Fund Activity: Q2 2025 in Review
18 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2025, worth a combined $9.5M — down 55% from $21.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LABD positions and 4 closed out — a net gain of 3 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Jane Street, adding an estimated $1.7M. The largest seller was Virtu Financial, cutting an estimated $7.1M.
- 18 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2025, up from 15 in Q1 2025.
- Funds reported $9.5M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2025, down 55% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2025 and 4 closed out, a net change of +3 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2025 was Jane Street, an estimated $1.7M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2025 was Virtu Financial, an estimated $7.1M sold.
Based on aggregated 13F filings for Q2 2025.